Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

With its stock down 12% over the past three months, it is easy to disregard Johnson & Johnson (NYSE:JNJ). However, stock ...

Johnson & Johnson (JNJ) stock saw a decline, ending the day at $149.23 which represents a decrease of $-0.37 or -0.25% from the prior close of $149.6. The stock opened at $149.93 and touched a low of ...

Kaustubh Bagalkote GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex GSK's Blenrep combo demonstrates significant survival benefits and improved efficacy in ...

Currently, the analyst consensus on Johnson & Johnson is a Moderate Buy with an average price target of $176.92, representing a 20.98% upside. In a report released on December 11, Citi also maintained ...

Key Insights Given the large stake in the stock by institutions, Johnson & Johnson's stock price might be vulnerable ...

Shares of Johnson & Johnson JNJ slid 0.27% to $146.24 Thursday, on what proved to be an all-around rough trading session for ...

Johnson & Johnson (JNJ) stock saw a decline, ending the day at $152.36 which represents a decrease of $-2.44 or -1.58% from the prior close of $154.8. The stock opened at $154.8 and touched a low of ...

Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades. Delving into the details, we found 20% ...

Johnson & Johnson an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of JNJ ...

Notably, the $205 average of analysts’ price estimate for ABBV, reflects over 20% upside from its current levels of around $165. While ABBV stock may outperform JNJ stock in the next three years ...

This was the stock's second consecutive day of losses.